Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000921895-18-003324
Filing Date
2018-12-17
Accepted
2018-12-17 16:45:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 7 TO THE SCHEDULE 13D sc13da706922004_12172018.htm SC 13D/A 70816
  Complete submission text file 0000921895-18-003324.txt   72158
Mailing Address 611 SOUTH FORT HARRISON AVE SUITE 306 CLEARWATER FL 33756
Business Address
DUGGAN ROBERT W (Filed by) CIK: 0001055919 (see all company filings)

Type: SC 13D/A

Mailing Address 3957 POINT EDEN WAY HAYWARD CA 94545
Business Address 3957 POINT EDEN WAY HAYWARD CA 94545 510-906-4600
Pulse Biosciences, Inc. (Subject) CIK: 0001625101 (see all company filings)

EIN.: 465696597 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-89516 | Film No.: 181238565
SIC: 3841 Surgical & Medical Instruments & Apparatus